Skip to main content

Table 3 Results of cox regression multivariate 5-year survival analysis of the patients with non-small cell lung cancer

From: Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer

 BSEWaldPHR95.0% CI for HR
Gender0.5730.4091.9680.1611.7740.796–3.951
Age− 0.3320.3720.7960.3720.7180.346–1.488
Somking− 0.0790.4670.0290.8650.9240.370–2.307
Histological type− 0.7550.4361.3350.2481.4240.782–2.594
Differentiation0.3530.3062.7570.0971.7070.908–3.209
pT0.4550.3901.3570.2441.5760.733–3.387
pN1.9480.6568.8050.0037.0111.937–25.379
pTNM0.0550.4010.0190.8901.0570.482–2.318
Chemotherapy− 0.7490.5761.6920.1930.4730.153–1.462
Radiotherapy0.2570.3810.4550.5001.2930.613–2.726
EGFR-TKI therapy− 0.0720.5030.0200.85870.9310.348–2.493
KIF21B0.9000.4395.0810.00402.4601.041–5.811
  1. B regression coefficient, SE standard error, Wald Wald value, HR hazard ratio, CI confidence interval